IQVIA provides a total solution based on big data
By Eo, Yun-Ho | translator Choi HeeYoung
21.05.19 14:51:29
°¡³ª´Ù¶ó
0
IQVIA's Korean subsidiary acquired CoreZetta and MMK
¡ãCEO Jeong Su-Yong
IQVIA(CRO Quintiles & IMS Healths) is much bigger than before. In addition to simply providing clinical referral and sales data, IQVIA includes development, release, and subsequent marketing and Rx management.IQVIA Korea, a so-called 'Human Data Science Company', recently acquired CoreZetta, a sample big data analysis company of the HIRA, and MMK Communications, a healthcare marketing company, to upgrade the reliability and service area of the data. The number of executives and employees of Korean subsidiaries has already surpassed 780.
Dailypharm met with CEO Jeong Su-Yong (48 yrs old), who has been leading IQVIA Korea since 2017, and heard about IQVIA's vision and strategy.
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)